UNSPSC 51385611: Sulfosalicylic acid

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C7H6O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L8XED79U3U, chemically known as salicylic acid, sulfo- but generally known as sulfosalicylic acid, which bears US NIH Compound Identifier 7322. As of Q4 2014, SULFOSALICYLIC ACID remains the US FDA Preferred Term for this commodity. Sulfosalicylic acid bears US NLM identifiers UMLS ID C0075593 and NCI Concept Code C84186. SMILES: C1=CC(=C(C=C1S(=O)(=O)O)C(=O)O)O.

UNSPSC 51385611 Sulfosalicylic acid, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal scope. The three most recent opportunities tagged to this code involve naloxone and drug deactivation systems, a direct-to-manufacturer prescription program framework, and generic multi-source pharmaceuticals and over-the-counter products — none of which constitute sulfosalicylic acid procurement. The mismatch between the code's chemical specificity and the health-care and pharmaceutical-supply activities appearing in recent solicitations suggests either broad mis-tagging by issuing bodies or that this code tier is not actively used for targeted procurement of the chemical itself in state and local markets.

Activity spans Florida county health procurement, Texas state health and human services policy, and Minnesota cooperative purchasing for multi-state distribution, indicating geographic dispersion across three distinct regional markets and procurement models. Seminole County, Florida posted an IFB (IFB60459723LAS, due July 26, 2023) for naloxone and drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building. The Texas Health and Human Services Commission issued an RFI (HHS0017013, April 3, 2026 response deadline) to gather vendor capabilities for a direct-to-manufacturer prescription initiative outside traditional pharmacy benefit manager channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) posted an RFP (S1070000015802, March 26, 2026 response deadline) for generic pharmaceuticals and OTC products through authorized wholesalers, effective July 1, 2026. No opportunities under this code directly solicit sulfosalicylic acid or related chemical products; business development activity should focus on higher-tier pharmaceutical or chemical family codes or direct engagement with state pharmaceutical procurement offices rather than this Commodity code.